Search

everythinglearnresearchcommunity

for

Search:↓

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Netherton Syndrome is a non-treatable genetic disorder in children causing skin, hair, and allergy issues.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Topical treatments led to hair regrowth in a man with linear morphea.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

Netherton syndrome can cause severe and chronic vulvovaginal symptoms that may improve with continuous oral contraceptives.

Phototherapy can help treat hair loss in alopecia areata.

Platelet-rich plasma mesotherapy improved symptoms in patients with corticosteroid-induced rosacea-like dermatitis.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Naproxen effectively treated a girl's eosinophilic pustular folliculitis when other treatments failed.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

The combination therapy improved skin pigmentation.

Biodegradable microneedle patches help topical steroids work better for prurigo nodularis.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Strong skin creams work well for long-term scalp inflammation in Rapp-Hodgkin Ectodermal Dysplasia.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.